Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Revolution Medicines, Inc. Common Stock

RVMD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of RVMD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RVMD Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
RVMD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RVMD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in RVMD holdings by institutional investors

Quarterly net insider trading by RVMD's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for RVMD

Quiver Logo

No former government officials on record as having lobbied for RVMD

Revolving Door Dashboard

RVMD Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

RVMD Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RVMD Income Statement
RVMD Balance Sheet
RVMD Cash Flow
U.S. Patents

New RVMD patent grants

  • Patent Title: Ras inhibitors May. 12, 2026
  • Patent Title: Method and system for monitoring and controlling high risk substances Mar. 24, 2026
  • Patent Title: 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors Mar. 03, 2026
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Feb. 10, 2026
  • Patent Title: Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a shp2 inhibitor Jan. 20, 2026
  • Patent Title: Ras inhibitors Nov. 11, 2025
  • Patent Title: Ras inhibitors Sep. 09, 2025
  • Patent Title: Ras inhibitors Sep. 02, 2025
  • Patent Title: Ras inhibitors Aug. 12, 2025
  • Patent Title: Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric shp2 inhibitors Jul. 22, 2025
  • Patent Title: Ras inhibitors Apr. 22, 2025
  • Patent Title: Bicyclic heteroaryl compounds and uses thereof Mar. 25, 2025
  • Patent Title: Ras inhibitors Mar. 18, 2025
  • Patent Title: Ras inhibitors Jan. 21, 2025
  • Patent Title: C26-linked rapamycin analogs as mtor inhibitors Jan. 07, 2025
  • Patent Title: Methods of treating cancer with an mtor inhibitor Oct. 22, 2024
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Jul. 30, 2024
  • Patent Title: Compounds that participate in cooperative binding and uses thereof May. 21, 2024
  • Patent Title: Ras inhibitors Apr. 09, 2024
  • Patent Title: Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric shp2 inhibitors Aug. 29, 2023
  • Patent Title: Ras inhibitors Aug. 29, 2023
  • Patent Title: Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors Jul. 18, 2023
  • Patent Title: Ras inhibitors Jul. 04, 2023
  • Patent Title: C26-linked rapamycin analogs as mtor inhibitors Jun. 27, 2023
  • Patent Title: Polycyclic compounds as allosteric shp2 inhibitors Jun. 13, 2023
  • Patent Title: Pyridine compounds as allosteric shp2 inhibitors Jun. 13, 2023
  • Patent Title: 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors May. 30, 2023
  • Patent Title: Identifying new therapeutic agents May. 09, 2023
  • Patent Title: Polycyclic compounds as allosteric shp2 inhibitors Apr. 25, 2023
  • Patent Title: Ras inhibitors Mar. 21, 2023
  • Patent Title: Shp2 inhibitor compositions and methods for treating cancer Mar. 07, 2023
  • Patent Title: Ras inhibitors Jan. 31, 2023
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Jun. 21, 2022
  • Patent Title: Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a shp2 inhibitor Jan. 11, 2022
  • Patent Title: Bicyclic heteroaryl compounds and uses thereof Nov. 09, 2021
  • Patent Title: Compounds that participate in cooperative binding and uses thereof Jul. 13, 2021
  • Patent Title: Identifying new therapeutic agents Apr. 27, 2021
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Apr. 20, 2021
  • Patent Title: Methods and reagents for analyzing protein-protein interfaces Mar. 16, 2021
  • Patent Title: 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors Mar. 17, 2020
  • Patent Title: Compounds that participate in cooperative binding and uses thereof Jan. 14, 2020
  • Patent Title: Methods and reagents for analyzing protein-protein interfaces Nov. 05, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to RVMD from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
RVMD News

Recent insights relating to RVMD

CNBC Recommendations

Recent picks made for RVMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RVMD

RVMD Analyst Ratings

RVMD Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RVMD Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RVMD stock a Buy, Sell, or Hold?

  • What is the price target for $RVMD stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RVMD Top Shareholders
Shareholder
Shares Held
RVMD Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RVMD stock?

  • Who owns the most shares of $RVMD stock?

  • What funds own $RVMD stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RVMD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RVMD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About RVMD

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

  • Address Redwood City, CA
  • Market Cap 40.9 billion
  • Employees 883
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc. Common Stock (RVMD) Historical Stock Prices

Revolution Medicines, Inc. Common Stock (RVMD) closed at $190.74 on September 23, 2026. Over the past year its adjusted close ranged from $42.51 to $221.15. Daily prices go back to February 13, 2020, 1,661 trading days in all.

  • 1 month-9.85%
  • 3 months+12.35%
  • Year to date+139.47%
  • 1 year+331.49%
  • 3 years+535.80%
  • 5 years+521.10%
  • Max+560.00%
See every congressional and insider trade on the RVMD price chart

Quiver Premium charts RVMD's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 193.30 196.71 189.05 190.74 190.74 2,124,868
Sep 22, 2026 191.56 195.28 191.22 192.86 192.86 1,882,365
Sep 21, 2026 192.60 194.93 190.57 192.76 192.76 1,888,942
Sep 18, 2026 197.00 197.10 188.18 190.95 190.95 5,940,042
Sep 17, 2026 198.53 202.02 194.80 196.94 196.94 1,821,131
Sep 16, 2026 204.84 205.15 193.58 195.92 195.92 3,036,953
Sep 15, 2026 206.98 207.00 200.24 204.86 204.86 1,268,755
Sep 14, 2026 203.50 206.55 200.17 205.11 205.11 1,274,550
Sep 11, 2026 204.98 206.36 197.81 203.77 203.77 1,378,678
Sep 10, 2026 205.85 207.84 202.59 203.35 203.35 810,664
Sep 9, 2026 206.01 213.00 204.46 207.68 207.68 1,227,174
Sep 8, 2026 208.07 213.00 206.30 207.32 207.32 2,390,452
Sep 4, 2026 209.01 211.75 207.48 210.02 210.02 885,061
Sep 3, 2026 207.04 212.06 207.04 210.87 210.87 1,119,610
Sep 2, 2026 211.36 211.91 205.22 209.23 209.23 1,333,392
Sep 1, 2026 204.64 210.25 202.54 209.87 209.87 1,834,261
Aug 31, 2026 205.14 207.02 200.53 205.57 205.57 2,269,459
Aug 28, 2026 221.50 221.50 205.82 207.88 207.88 2,006,480
Aug 27, 2026 219.48 224.31 216.13 221.15 221.15 3,362,386
Aug 26, 2026 209.32 218.30 198.91 215.44 215.44 3,524,075
Aug 25, 2026 214.27 216.24 209.63 211.38 211.38 1,377,734
Aug 24, 2026 209.46 211.95 205.39 211.58 211.58 1,598,295
Aug 21, 2026 212.06 212.74 206.75 209.46 209.46 2,124,325
Aug 20, 2026 212.26 213.74 208.02 211.74 211.74 1,563,624
Aug 19, 2026 218.84 220.34 212.25 214.66 214.66 1,308,104
Aug 18, 2026 209.15 216.72 209.09 216.00 216.00 1,651,903
Aug 17, 2026 204.02 215.97 203.18 212.00 212.00 2,440,303
Aug 14, 2026 201.50 204.00 198.89 203.71 203.71 784,252
Aug 13, 2026 206.85 206.85 201.02 202.00 202.00 986,762
Aug 12, 2026 206.99 208.49 203.75 205.26 205.26 1,175,945
Aug 11, 2026 207.26 208.25 202.01 205.55 205.55 1,681,001
Aug 10, 2026 205.70 208.76 203.70 206.97 206.97 2,101,103
Aug 7, 2026 200.82 205.90 196.49 205.15 205.15 1,665,276
Aug 6, 2026 197.72 203.00 195.42 197.81 197.81 1,747,582
Aug 5, 2026 194.05 198.29 192.56 197.30 197.30 1,952,902
Aug 4, 2026 183.53 194.07 181.02 193.46 193.46 1,614,237
Aug 3, 2026 184.43 186.25 180.14 182.45 182.45 1,827,053
Jul 31, 2026 192.00 192.00 186.15 187.53 187.53 1,491,943
Jul 30, 2026 183.72 192.76 182.00 192.17 192.17 1,807,327
Jul 29, 2026 184.21 185.04 178.07 180.92 180.92 2,299,333
Jul 28, 2026 186.60 188.68 181.49 183.86 183.86 2,401,464
Jul 27, 2026 188.91 194.56 186.98 188.07 188.07 1,426,021
Jul 24, 2026 189.23 190.50 185.89 189.23 189.23 1,288,032
Jul 23, 2026 182.61 193.53 180.00 188.75 188.75 2,283,154
Jul 22, 2026 180.66 185.40 180.11 183.03 183.03 888,843
Jul 21, 2026 181.25 184.25 179.39 183.29 183.29 2,300,063
Jul 20, 2026 186.64 189.85 180.16 180.39 180.39 2,538,696
Jul 17, 2026 176.87 186.66 176.00 186.16 186.16 1,832,639
Jul 16, 2026 183.56 184.86 177.18 179.18 179.18 1,725,137
Jul 15, 2026 183.12 185.97 181.17 184.44 184.44 1,538,128
Jul 14, 2026 186.60 188.69 183.92 184.97 184.97 3,123,169
Jul 13, 2026 182.78 186.00 180.10 183.95 183.95 1,705,724
Jul 10, 2026 192.22 192.33 184.79 186.88 186.88 1,355,271
Jul 9, 2026 190.05 193.82 190.04 191.13 191.13 1,610,192
Jul 8, 2026 190.00 193.48 186.78 189.77 189.77 1,983,108
Jul 7, 2026 189.65 192.92 186.56 190.46 190.46 1,893,546
Jul 6, 2026 192.25 193.69 188.68 189.99 189.99 2,398,427
Jul 2, 2026 188.37 189.48 184.28 189.24 189.24 3,190,772
Jul 1, 2026 185.49 188.46 182.82 187.51 187.51 2,079,326
Jun 30, 2026 189.53 193.09 184.58 187.28 187.28 4,000,606
Jun 29, 2026 182.26 192.80 181.50 192.62 192.62 5,314,526
Jun 26, 2026 175.19 183.36 174.26 182.08 182.08 9,544,060
Jun 25, 2026 170.94 184.39 168.19 178.17 178.17 5,508,269
Jun 24, 2026 170.50 170.65 166.43 169.77 169.77 3,626,452
Jun 23, 2026 163.30 171.25 163.05 169.51 169.51 3,124,242
Jun 22, 2026 162.32 166.84 162.15 165.81 165.81 3,129,266
Jun 18, 2026 160.66 164.78 158.40 162.99 162.99 4,702,503
Jun 17, 2026 156.75 161.63 156.44 157.77 157.77 2,227,786
Jun 16, 2026 158.28 158.70 153.94 156.58 156.58 2,523,689
Jun 15, 2026 155.00 160.41 152.88 160.06 160.06 2,131,789
Jun 12, 2026 150.40 154.74 149.67 153.87 153.87 1,581,068
Jun 11, 2026 144.62 150.35 143.47 149.23 149.23 2,201,974
Jun 10, 2026 148.88 149.04 141.44 144.19 144.19 3,283,137
Jun 9, 2026 150.23 151.50 146.47 149.55 149.55 2,766,870
Jun 8, 2026 150.10 152.10 147.41 148.49 148.49 2,734,779
Jun 5, 2026 153.67 154.97 148.15 149.23 149.23 2,140,414
Jun 4, 2026 156.28 159.34 154.60 155.69 155.69 2,609,527
Jun 3, 2026 151.57 156.87 151.52 155.99 155.99 2,008,033
Jun 2, 2026 161.23 162.76 151.29 151.31 151.31 3,750,390
Jun 1, 2026 159.95 166.50 154.13 163.68 163.68 6,730,919
May 29, 2026 155.66 158.13 153.18 157.48 157.48 6,661,368
May 28, 2026 153.47 155.88 149.10 154.63 154.63 2,650,835
May 27, 2026 153.69 155.76 150.95 153.00 153.00 2,881,879
May 26, 2026 153.12 155.00 152.23 154.89 154.89 2,393,478
May 22, 2026 154.42 156.25 151.44 151.56 151.56 1,935,096
May 21, 2026 150.33 154.71 150.22 153.73 153.73 1,846,187
May 20, 2026 149.74 153.55 148.02 150.33 150.33 2,402,518
May 19, 2026 144.53 147.93 141.79 147.30 147.30 1,995,895
May 18, 2026 145.03 146.91 141.00 144.37 144.37 2,345,020
May 15, 2026 147.84 148.85 141.25 145.66 145.66 2,475,768
May 14, 2026 150.00 150.79 146.50 149.47 149.47 1,804,990
May 13, 2026 146.89 150.30 145.26 149.94 149.94 1,844,543
May 12, 2026 144.00 146.11 141.18 145.72 145.72 1,422,929
May 11, 2026 142.56 145.52 141.57 144.15 144.15 1,640,884
May 8, 2026 142.56 144.61 140.53 141.81 141.81 2,514,425
May 7, 2026 148.80 149.78 142.08 142.51 142.51 3,175,037
May 6, 2026 146.72 151.43 145.29 151.07 151.07 2,946,296
May 5, 2026 148.66 149.87 144.26 147.21 147.21 3,321,768
May 4, 2026 141.15 148.25 140.95 147.90 147.90 2,470,753
May 1, 2026 143.50 149.30 139.39 139.48 139.48 2,584,284
Apr 30, 2026 141.43 144.29 138.75 144.12 144.12 2,314,565
Apr 29, 2026 143.03 144.15 139.78 140.55 140.55 2,790,639
Apr 28, 2026 146.22 150.00 141.61 144.83 144.83 5,585,373
Apr 27, 2026 137.17 137.25 131.02 131.67 131.67 4,816,531
Apr 24, 2026 134.58 138.44 132.00 135.30 135.30 3,501,685
Apr 23, 2026 141.79 143.94 133.05 134.48 134.48 4,275,182
Apr 22, 2026 149.67 149.68 141.00 141.50 141.50 3,731,761
Apr 21, 2026 147.00 149.36 143.17 148.90 148.90 2,828,131
Apr 20, 2026 151.85 153.50 146.17 146.23 146.23 3,495,621
Apr 17, 2026 149.48 151.13 145.52 148.63 148.63 4,759,878
Apr 16, 2026 152.55 155.70 147.30 149.27 149.27 5,701,859
Apr 15, 2026 149.51 155.01 147.63 152.54 152.54 11,938,463
Apr 14, 2026 136.50 148.00 134.66 147.01 147.01 8,202,306
Apr 13, 2026 132.26 136.80 127.00 136.30 136.30 14,720,636
Apr 10, 2026 97.03 97.22 94.63 96.43 96.43 1,984,964
Apr 9, 2026 96.75 98.00 94.70 96.22 96.22 1,283,269
Apr 8, 2026 98.99 99.00 95.80 96.75 96.75 1,203,521
Apr 7, 2026 95.51 96.36 94.00 96.29 96.29 1,035,234
Apr 6, 2026 98.19 98.73 95.03 95.36 95.36 1,743,881
Apr 2, 2026 96.47 101.00 96.47 99.12 99.12 1,331,711
Apr 1, 2026 98.67 99.96 97.19 98.64 98.64 2,185,988
Mar 31, 2026 94.21 98.10 94.04 97.25 97.25 3,247,537
Mar 30, 2026 92.49 93.88 91.52 92.71 92.71 1,747,144
Mar 27, 2026 93.17 95.31 92.09 92.51 92.51 1,102,839
Mar 26, 2026 93.68 95.11 93.05 93.21 93.21 1,703,169
Mar 25, 2026 96.54 97.37 92.59 94.29 94.29 2,483,675
Mar 24, 2026 96.16 97.44 95.42 95.52 95.52 1,528,879
Mar 23, 2026 96.86 98.80 96.14 96.63 96.63 1,366,524
Mar 20, 2026 97.97 98.98 94.87 95.78 95.78 3,380,707
Mar 19, 2026 97.44 100.08 97.42 99.29 99.29 1,488,998
Mar 18, 2026 99.13 99.52 97.26 98.11 98.11 2,210,399
Mar 17, 2026 98.12 100.51 97.10 99.13 99.13 1,865,655
Mar 16, 2026 96.60 99.64 96.60 99.00 99.00 1,542,284
Mar 13, 2026 96.44 99.09 94.67 94.86 94.86 1,465,622
Mar 12, 2026 98.34 99.17 95.04 95.07 95.07 2,255,283
Mar 11, 2026 98.19 100.14 96.52 99.59 99.59 2,294,558
Mar 10, 2026 99.74 101.38 98.70 98.86 98.86 2,104,308
Mar 9, 2026 98.93 99.90 97.63 99.79 99.79 1,498,022
Mar 6, 2026 98.17 100.08 97.31 98.40 98.40 1,601,104
Mar 5, 2026 100.44 101.06 98.19 99.64 99.64 1,705,176
Mar 4, 2026 101.34 102.00 100.37 101.19 101.19 1,568,206
Mar 3, 2026 98.98 102.36 97.61 100.49 100.49 1,875,078
Mar 2, 2026 101.50 102.34 97.78 101.62 101.62 2,475,475
Feb 27, 2026 102.10 104.31 100.52 102.02 102.02 10,308,387
Feb 26, 2026 95.47 104.08 95.25 102.15 102.15 1,994,153
Feb 25, 2026 105.90 107.45 102.38 103.24 103.24 2,823,170
Feb 24, 2026 103.69 105.30 103.28 104.83 104.83 1,950,241
Feb 23, 2026 101.84 103.83 100.98 103.69 103.69 1,670,058
Feb 20, 2026 102.72 102.82 100.20 101.83 101.83 1,694,604
Feb 19, 2026 99.58 103.69 98.38 102.74 102.74 1,801,603
Feb 18, 2026 100.60 101.53 98.71 99.79 99.79 1,594,729
Feb 17, 2026 96.80 100.62 96.00 100.61 100.61 1,484,294
Feb 13, 2026 97.84 99.01 95.97 96.31 96.31 1,585,294
Feb 12, 2026 98.65 98.79 97.12 97.33 97.33 1,553,021
Feb 11, 2026 96.64 98.41 93.79 97.99 97.99 2,319,576
Feb 10, 2026 96.90 97.36 94.95 95.98 95.98 1,667,463
Feb 9, 2026 97.27 97.81 95.88 96.74 96.74 1,471,596
Feb 6, 2026 97.50 99.58 96.43 97.49 97.49 2,135,177
Feb 5, 2026 96.15 97.99 95.51 96.15 96.15 1,881,720
Feb 4, 2026 96.44 97.08 93.02 96.51 96.51 2,447,294
Feb 3, 2026 97.96 98.64 94.89 95.97 95.97 2,417,200
Feb 2, 2026 96.52 97.50 95.30 97.16 97.16 2,540,587
Jan 30, 2026 98.01 99.49 96.63 96.95 96.95 2,090,541
Jan 29, 2026 97.00 100.18 96.78 98.20 98.20 2,478,138
Jan 28, 2026 99.04 100.30 96.72 97.33 97.33 3,133,818
Jan 27, 2026 98.14 101.93 97.75 99.82 99.82 3,567,210
Jan 26, 2026 93.50 99.51 92.50 97.78 97.78 10,177,785
Jan 23, 2026 118.40 120.63 117.59 117.63 117.63 2,522,362
Jan 22, 2026 118.36 120.53 116.55 118.81 118.81 3,188,795
Jan 21, 2026 115.60 118.43 114.81 117.53 117.53 3,876,286
Jan 20, 2026 118.59 119.75 113.96 116.22 116.22 5,311,354
Jan 16, 2026 124.45 124.49 119.61 120.28 120.28 4,798,696
Jan 15, 2026 120.70 124.16 120.70 123.27 123.27 2,968,894
Jan 14, 2026 119.82 122.12 118.15 121.22 121.22 3,692,722
Jan 13, 2026 118.16 121.30 117.78 119.95 119.95 3,882,243
Jan 12, 2026 116.82 118.48 113.33 117.17 117.17 6,180,101
Jan 9, 2026 120.00 121.61 109.77 118.64 118.64 20,793,757
Jan 8, 2026 95.21 112.43 94.52 107.39 107.39 13,607,298
Jan 7, 2026 80.95 105.00 79.94 102.71 102.71 14,855,434
Jan 6, 2026 78.51 80.39 77.76 79.85 79.85 2,224,788
Jan 5, 2026 78.44 78.94 76.28 78.33 78.33 3,279,310
Jan 2, 2026 80.29 80.47 77.86 79.02 79.02 1,381,633
Dec 31, 2025 79.68 80.30 79.45 79.65 79.65 844,931
Dec 30, 2025 80.18 80.50 78.97 79.67 79.67 1,267,267
Dec 29, 2025 80.01 80.92 79.80 80.52 80.52 2,035,208
Dec 26, 2025 81.22 81.58 80.01 80.75 80.75 1,113,796
Dec 24, 2025 80.51 81.97 80.01 81.19 81.19 1,400,396
Dec 23, 2025 80.57 81.71 79.91 80.27 80.27 1,106,124
Dec 22, 2025 78.40 81.62 78.40 80.58 80.58 1,814,755
Dec 19, 2025 77.56 79.10 76.45 78.78 78.78 6,313,981
Dec 18, 2025 76.79 77.71 74.20 75.96 75.96 2,967,644
Dec 17, 2025 77.46 77.83 75.82 76.74 76.74 2,842,559
Dec 16, 2025 76.09 78.41 73.00 77.56 77.56 4,498,012
Dec 15, 2025 78.43 79.95 78.17 79.00 79.00 3,187,651
Dec 12, 2025 78.85 80.44 78.05 78.92 78.92 2,240,032
Dec 11, 2025 78.30 79.60 77.54 78.51 78.51 2,023,990
Dec 10, 2025 78.41 79.88 77.81 77.88 77.88 2,328,230
Dec 9, 2025 79.59 79.99 77.31 77.81 77.81 2,265,000
Dec 8, 2025 80.00 81.49 78.67 80.06 80.06 2,532,833
Dec 5, 2025 78.48 79.81 77.89 79.64 79.64 1,712,953
Dec 4, 2025 77.45 79.06 76.53 78.48 78.48 2,133,047
Dec 3, 2025 75.55 79.07 74.52 77.69 77.69 3,100,620
Dec 2, 2025 75.50 77.22 74.97 75.31 75.31 1,492,966
Dec 1, 2025 77.06 77.33 75.11 75.80 75.80 1,687,215
Nov 28, 2025 77.68 77.98 76.60 77.76 77.76 850,035
Nov 26, 2025 76.12 78.17 75.65 77.58 77.58 1,498,200
Nov 25, 2025 73.66 76.41 73.44 76.32 76.32 2,051,288
Nov 24, 2025 71.26 73.98 71.15 73.66 73.66 2,732,299
Nov 21, 2025 70.07 71.97 69.50 70.87 70.87 1,941,864
Nov 20, 2025 71.65 72.72 69.75 69.88 69.88 2,351,830
Nov 19, 2025 70.06 71.62 69.85 70.53 70.53 2,010,250
Nov 18, 2025 68.97 70.92 67.86 70.58 70.58 2,626,771
Nov 17, 2025 67.65 69.50 67.27 69.14 69.14 2,713,881
Nov 14, 2025 63.84 69.02 63.50 67.75 67.75 3,958,489
Nov 13, 2025 65.53 66.11 63.95 64.38 64.38 2,663,515
Nov 12, 2025 64.05 66.00 63.51 65.83 65.83 2,768,055
Nov 11, 2025 62.29 64.26 62.29 64.08 64.08 2,033,174
Nov 10, 2025 61.74 63.13 61.50 62.73 62.73 3,523,141
Nov 7, 2025 60.86 61.40 58.91 61.01 61.01 2,724,421
Nov 6, 2025 59.73 63.15 59.40 61.38 61.38 2,850,554
Nov 5, 2025 58.53 60.00 58.00 59.34 59.34 2,396,210
Nov 4, 2025 57.99 59.68 57.74 58.57 58.57 2,118,455
Nov 3, 2025 58.93 59.44 56.66 59.33 59.33 2,545,209
Oct 31, 2025 58.96 59.74 58.28 58.84 58.84 2,378,272
Oct 30, 2025 57.83 60.08 57.33 58.87 58.87 2,191,134
Oct 29, 2025 58.19 58.85 57.23 58.02 58.02 1,640,887
Oct 28, 2025 57.86 58.66 57.53 58.17 58.17 1,915,172
Oct 27, 2025 55.53 58.62 55.40 57.99 57.99 3,629,051
Oct 24, 2025 54.00 55.32 53.66 54.48 54.48 1,972,685
Oct 23, 2025 53.15 54.08 52.48 53.44 53.44 1,867,589
Oct 22, 2025 53.50 54.49 52.62 52.98 52.98 1,852,672
Oct 21, 2025 54.76 55.20 53.17 53.49 53.49 1,605,980
Oct 20, 2025 55.00 55.28 53.47 54.01 54.01 2,136,166
Oct 17, 2025 52.76 56.15 52.40 54.10 54.10 4,586,607
Oct 16, 2025 50.00 51.70 49.05 49.68 49.68 1,774,602
Oct 15, 2025 47.63 49.83 47.45 49.56 49.56 2,300,503
Oct 14, 2025 48.53 48.77 47.50 47.50 47.50 2,113,834
Oct 13, 2025 48.24 49.00 48.00 48.75 48.75 1,455,663
Oct 10, 2025 47.64 49.10 47.28 48.24 48.24 2,492,179
Oct 9, 2025 47.84 48.35 47.45 47.62 47.62 1,118,642
Oct 8, 2025 46.95 49.50 46.16 47.82 47.82 3,085,218
Oct 7, 2025 46.92 47.02 45.80 46.57 46.57 900,764
Oct 6, 2025 46.90 47.33 46.34 46.58 46.58 2,047,185
Oct 3, 2025 45.98 47.60 45.72 46.71 46.71 1,779,343
Oct 2, 2025 46.18 46.44 45.60 45.70 45.70 1,487,209
Oct 1, 2025 46.54 47.08 45.83 45.86 45.86 3,140,452
Sep 30, 2025 45.91 46.80 45.49 46.70 46.70 1,615,010
Sep 29, 2025 44.05 47.22 44.05 46.07 46.07 3,795,755
Sep 26, 2025 42.79 44.02 42.78 43.92 43.92 1,934,354
Sep 25, 2025 43.12 43.59 42.18 42.51 42.51 1,531,277
Sep 24, 2025 44.26 44.88 43.16 43.54 43.54 1,919,111
Sep 23, 2025 44.18 44.55 43.91 44.20 44.20 1,547,337

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Revolution Medicines, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at RVMD, per a recent SEC DEF 14A filing. We estimate that the median employee at Revolution Medicines, Inc. is paid $365,127.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation